Blueprint Medicines shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Blueprint Medicines by Capital Impact Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $675k | 11k | 63.20 |
| 2023-03-31 | $456k | 10k | 44.99 |
| 2022-12-31 | $321k | 7.3k | 43.81 |
| 2022-09-30 | $312k | 7.3k | 42.59 |
| 2022-06-30 | $303k | 6.0k | 50.46 |
| 2022-03-31 | $537k | 8.4k | 63.85 |
| 2021-12-31 | $821k | 7.7k | 107.08 |